Danielle-Barbara Varas
Psychiatric/Mental Health · Brooklyn, NYNPI 1326386913
Payments from drug & device makers
Across 63 payments — averaging $113.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$2K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$969
- Supernus Pharmaceuticals, Inc.$894
- AbbVie$525
- Novo Nordisk$313
- Boehringer Ingelheim$250
- plus $2K from 14 others
What the payments were for
- Speaking & faculty fees$5007%
- Food & beverage$6,63693%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 19 | $2,063 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 8 | $969 |
| Supernus Pharmaceuticals, Inc. | 10 | $894 |
| AbbVie | 4 | $525 |
| Novo Nordisk | 3 | $313 |
| Boehringer Ingelheim | 2 | $250 |
| Calliditas Therapeutics US Inc. | 2 | $250 |
| Gilead | 2 | $247 |
| Impel Pharmaceuticals Inc. | 2 | $218 |
| Neurocrine Biosciences, Inc. | 1 | $174 |
| Johnson & Johnson | 1 | $150 |
| Sage Therapeutics, LLC | 1 | $146 |
| Shield Therapeutics Inc | 1 | $146 |
| Madrigal Pharmaceuticals | 1 | $135 |
| E.r. Squibb & Sons, L.L.C. | 1 | $126 |
| Abiomed | 1 | $125 |
| Viiv Healthcare Company | 1 | $122 |
| Mylan Specialty L.p. | 1 | $121 |
| Alkermes, Inc. | 1 | $117 |
| Teva Pharmaceuticals USA, Inc. | 1 | $45 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REXULTI$1,020
- ABILIFY MAINTENA$650
- LYBALVI$470
- ABILIFY ASIMTUFII$400
- BOTOX$275
- QELBREE$250
- TARPEYO$250
- INGREZZA$174
- INVEGA SUSTENNA$150
- INVEGA TRINZA$150
- ACCRUFER$146
- REZDIFFRA$135
- Trudhesa$127
- COBENFY$126
- VRAYLAR$125
- Vemlidy$125
- DOVATO$122
- Yupelri$121
- Ozempic$115
How this compares
$7,136 in reported general payments places this provider in the 95th percentile of 2,385 psychiatric/mental health providers in New York.
Other psychiatric/mental health in Brooklyn
- Leunz CadelyBrooklyn$13K
- Ellen KudrowBrooklyn$12K
- Rosemary FordjourBrooklyn$12K
- Tiffany LawsonBrooklyn$11K
- Glenn HannDansville$1.3M
- Tammy RussoNiskayuna$568K
- Carrie EdickSchenectady$484K
- Eric SpronzCentereach$448K
- Terry Jo Brooks-DevlinTonawanda$176K
- Kevin SiewersStaten Island$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.